PMA P830063S018

Device
Prismaflex TPE2000 Set
Applicant
Vantive US Healthcare, LLC
Product code
MDP
Decision date
2021-07-16
Generic name
Separator for therapeutic purposes, membrane automated blood cell/plasma
Approval order statement
Approval for a material composition change for a component of the Prismaflex TPE2000 Set, specifically the change to the PVC material used for the production of the fluid pump segments of the Prismaflex TPE 2000 Set.

Current openFDA PMA Record#

Device
Prismaflex TPE2000 Set
Applicant
Vantive US Healthcare, LLC
PMA number
P830063
Supplement
S018
Product code
MDP
Generic name
Separator for therapeutic purposes, membrane automated blood cell/plasma
Decision date
2021-07-16
Decision code
APPR
Date received
2021-04-19
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
Approval for a material composition change for a component of the Prismaflex TPE2000 Set, specifically the change to the PVC material used for the production of the fluid pump segments of the Prismaflex TPE 2000 Set.